NCT00002139CompletedPhase 1
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Pfizer
- Locations
- 2
Study Overview
Brief Summary
To compare the uptake of azithromycin in white cells relative to plasma concentrations in HIV-infected patients.
Detailed Description
Patients are randomized to receive azithromycin orally or intravenously, with crossover to the alternate treatment after a 21-day wash-out period.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Phase 1
Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With HemophiliaHemophilia AHIV InfectionsNCT00000705National Institute of Allergy and Infectious Diseases (NIAID)24
Completed
Phase 2
The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV DrugsHIV InfectionsNCT00001067National Institute of Allergy and Infectious Diseases (NIAID)105
Completed
Phase 1
A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineCytomegalovirus InfectionsHIV InfectionsNCT00002096Hoffmann-La Roche24
Unknown
Phase 4
Anti-viral Effects of Azithromycin in Patients With Asthma and COPDCOPDExacerbation CopdBronchial DiseasesLung Diseases, ObstructiveLung DiseasesImmune System DiseasesEosinophilic AsthmaAsthmaNCT04319705Bispebjerg Hospital100
Completed
Not Applicable
Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)PneumoniaPelvic Inflammatory DiseaseNCT01671280Pfizer403